Published 4 months ago • loading... • Updated 4 months ago

Biocytogen and Nanjing Chia Tai Tianqing Announce IND Approval in China for Co-Developed Anti-IGF-1R Antibody NTB003 (BCG009)

BEIJING & NANJING, China--(BUSINESS WIRE)--Jun 4, 2025-

Reposted by

Financial Post

BEIJING & NANJING, China--(BUSINESS WIRE)--Jun 4, 2025-

4 months ago

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources2

Leaning Left0Leaning Right1Center1Last Updated4 months agoBias Distribution

50% Center, 50% Right

50% Right

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

Post Register broke the news in 4 months ago on Wednesday, June 4, 2025.

Sources are mostly out of (0)